Best Practices for Working with the Sell-Side in the New Normal
This year has been one of tremendous change for the global capital markets, including changes in regulations and…
Industry Spotlight: Top Pharma Investor Relations Websites
Pharmaceutical companies have seen a surge in interest this year. The industry is attracting interest from both investors…
Industry Spotlight: Top Financial Sector Investor Relations Websites
It’s been a rough year for banks and the financial sector. Shortly after the new Current Expected Credit…
Navigating Phase Two of COVID-19: Three IR Tips for CFOs
Transparency and clarity of communication are central tenets of investor relations, especially during a crisis. To deliver this,…
How Small-Caps Are Surviving Post-Pandemic
With fewer internal resources and the lack of sell-side support that large- cap companies have, IR can be…
A Message from Q4 Addressing COVID-19 Concerns
To Q4 clients, partners, and stakeholders, As the coronavirus (COVID-19) continues to impact communities around the world, we…
Preparing for Earnings During the COVID-19 Crisis
The COVID-19 crisis has thrown all market participants – buy-side, sell-side, and corporate issuers – into a tailspin…